Bone health in anorexia nervosa

Current Opinion in Endocrinology and Diabetes

Volumn 13, Issue 1, 2006, Pages 26-30

  Soyka, Leslie A ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Adolescents; Anorexia nervosa; Bone density; Bone metabolism

Indexed keywords

ALENDRONIC ACID; ANABOLIC AGENT; ANDROGEN; BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ESTROGEN; GLUCOCORTICOID; HYDROCORTISONE; ORAL CONTRACEPTIVE AGENT; PAMIDRONIC ACID; PLACEBO; PRASTERONE; PROGESTERONE; RECOMBINANT LEPTIN; RECOMBINANT SOMATOMEDIN C; RISEDRONIC ACID; TESTOSTERONE; VITAMIN D;

AMENORRHEA; ANOREXIA NERVOSA; BODY WEIGHT; BONE DENSITY; BONE DISEASE; BONE MALFORMATION; BONE METABOLISM; BONE STRUCTURE; CLINICAL TRIAL; CONVALESCENCE; CORTICAL BONE; CORTICOSTEROID INDUCED OSTEOPOROSIS; DRUG EFFECT; DRUG SAFETY; HORMONAL THERAPY; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS; MALNUTRITION; OSSIFICATION; OSTEOPENIA; PATHOGENESIS; PILOT STUDY; REVIEW; SPINE; THICKNESS; TRABECULAR BONE;

EID: 33646937412     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.med.0000198071.59198.e0     Document Type: Review

References (44)

1. Misra M, Aggarwal A, Miller KK, et al. Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics 2004; 114:1574-1583. This paper provides the most complete summary of the frequency of medical complications in 60 adolescent girls with AN receiving outpatient care compared with healthy controls of a similar pubertal stage.
2. Grinspoon S, Thomas E, Pitts S, et al. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med 2000; 133:790-794.
3. Biller BMK, Saxe V, Herzog DB, et al. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab 1989; 68:548-554.
4. Seeman E, Karlsson MK, Duan Y. On exposure to anorexia nervosa, the temporal variation in axial and appendicular skeletal development predisposes to site-specific deficits in bone size and density: a cross-sectional study. J Bone Miner Res 2000; 15:2259-2265.
5. Milos G, Spindler A, Ruegsegger P, et al. Cortical and trabecular bone density and structure in anorexia nervosa. Osteoporos Int 2005; 16:783-790. This study is unique in measuring bone density with three different methods, including DEXA, quantitative ultrasound and three-dimensional peripheral QCT, in 30 young women with AN and 30 age-matched controls. The three-dimensional peripheral QCT technique demonstrated significant effects of AN on trabecular and cortical bone microarchitecture.
6. Rigotti NA, Neer RM, Skates SJ, et al. The clinical course of osteoporosis in anorexia nervosa. JAMA 1991; 265:1133-1138.
7. Herzog W, Minne H, Deter C, et al. Outcome of bone mineral density in anorexia nervosa patients 11.7 years after first admission. J Bone Miner Res 1993; 8:597-605.
8. Zipfel S, Seibel MJ, Lowe B, et al. Osteoporosis in eating disorders: a follow-up study of patients with anorexia and bulimia nervosa. J Clin Endocrinol Metab 2001; 86:5227-5233.
9. Wentz E, Mellstrom D, Gillberg C, et al. Bone density 11 years after anorexia nervosa onset in a controlled study of 39 cases. Int J Eat Disord 2003; 34:314-318.
10. Soyka LA, Grinspoon S, Levitsky LL, et al. The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab 1999; 84:4489-4496.
11. Soyka L, Misra M, Frenchman A, et al. Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2002; 87:4177-4185.
12. Grinspoon S, Baum H, Lee K, et al. Effects of short-term recombinant human insulin like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 1996; 81:3864-3870.
13. Compston JE, McConachie C, Stott C, et al. Changes in bone mineral density, body composition and biochemical markers of bone turnover during weight gain in adolescents with anorexia nervosa: a 1-year prospective study. Osteoporos Int 2005; E-pub ahead of print. 12 May 2005. This study expands information on longitudinal changes in bone density in adolescents with AN by including measurements of the femoral neck and total hip.
14. Bolton JGF, Patel S, Lacey JH, White S. A prospective study of changes in bone turnover and bone density associated with regaining weight in women with anorexia nervosa. Osteoporos Int 2005; E-pub ahead of print. 19 July 2005. This paper extends the follow-up of longitudinal changes in bone density and biochemical markers of bone turnover with weight recovery to a mean of 66 weeks in 15 young women with AN.
15. Misra M, Soyka LA, Miller KK, et al. Serum osteoprotegerin in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2003; 88:3816-3822.
16. Bachrach LK, Katzman DK, Litt IF, et al. Recovery from osteopenia in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 1991; 72:602-606.
17. Morishima A, Grumbach MM, Simpson ER, et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995; 80:3689-3698.
18. Bilezikian JP, Morishima A, Bell J, Grumbach MM. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 1998; 339:599-603.
19. Manolagas SC, Jilka RL. Bone marrow, cytokines and bone remodeling. N Engl J Med 1995; 332:305-311.
20. Pomeroy C, Eckert E, Hu S, et al. Role of interleukin-6 and transforming growth factor-B in anorexia nervosa. Biol Psychiatry 1994; 36:836-839.
21. Gordon CM, Goodman E, Emans SJ, et al. Physiologic regulators of bone turnover in young women with anorexia nervosa. J Pediatr 2002; 141:64-70.
22. Miller KK, Grieco KA, Klibanski A. Testosterone administration in women with anorexia nervosa. J Clin Endocrinol Metab 2005; 90:1428-1433. This randomized, placebo-controlled study is the first to look at the effects of transdermal testosterone on surrogate markers of bone metabolism in 33 osteopenic women with AN.
23. Devesa J, Perez-Fernandez R, Bokser L, et al. Adrenal androgen secretion and dopaminergic activity in anorexia nervosa. Horm Metab Res 1987; 20:57-60.
24. Gordon CM, Grace E, Emans SJ, et al. Changes in bone turnover markers and menstrual function after short-term oral DHEA in young women with anorexia nervosa. J Bone Miner Res 1999; 14:136-145.
25. Misra M, Miller KK, Bjornson J, et al. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 2003; 88:5615-5623.
26. Putignano P, Dubini A, Toja P, et al. Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol. Eur J Endocrinol 2001; 145:165-171.
27. Vergely N, Lafage-Proust M, Caillot-Augusseau A, et al. Hypercorticism blunts circadian variations in osteocalcin regardless of nutritional status. Bone 2002; 30:428-435.
28. Misra M, Miller KK, Almazan C, et al. Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 2004; 89:4972-4980. This paper analyses cortisol secretion in adolescent girls with AN in much greater detail than previous reports by using cluster and deconvolutional analyses, and reports correlations between cortisol levels and markers of nutritional status and bone formation.
29. Maccarinelli G, Sibilia V, Torsello A, et al. Ghrelin regulates proliferation and differentiation of osteoblastic cells. J Endocrinol 2005; 184:249-256.
30. Misra M, Miller KK, Stewart V, et al. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab 2005; E-pub ahead of print. 5 July 2005. This is the first study to examine ghrelin levels in relation to bone density in adolescent girls with AN and healthy controls of comparable maturity.
31. Tothill P, Hannan WJ, Cowen S, Freeman CP. Anomalies in the measurement of changes in total-body bone mineral by dual-energy x-ray absorptiometry during weight change. J Bone Miner Res 1997; 12:1908-1921.
32. Pitukcheewanont P, Safani D, Church J, et al. Bone measures in HIV-1 infected children and adolescents: disparity between quantitative computed tomography and dual-energy x-ray absorptiometry measurements. Osteoporos Int 2005; E-pub ahead of print. 9 February 2005.
33. Writing Group for the International Society for Clinical Densitometry Position Development Conference. Diagnosis of osteoporosis in men, premenopausal women and children. J Clin Densitom 2004; 7:17-26. This position paper from the International Society for Clinical Densitometry provides guidelines for the diagnosis of low bone density in children and adolescents.
34. Lucas AR, Melton JL, Crowson CS, O'Fallon WM. Long-term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin Proc 1999; 74:972-977.
35. Klibanski A, Biller BMK, Schoenfeld DA, et al. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 1995; 80:898-904.
36. Grinspoon S, Thomas L, Miller K, et al. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 2002; 87:2883-2891.
37. Harel Z, Riggs S. Transdermal versus oral administration of estrogen in the management of lumbar spine osteopenia in an adolescent with anorexia nervosa. J Adolesc Health 1997; 21:179-182.
38. Gordon CM, Grace E, Emans SJ, et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab 2002; 87:4935-4941.
39. Misra M, Miller KK, Almazan C, et al. Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. J Clin Endocrinol Metab 2004; 89:3486-3495.
40. Cock TA, Auwerx J. Leptin: cutting the fat off the bone. Lancet 2003; 362:1572-1574.
41. Welt CK, Chan JL, Bullen J, et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004; 351:987-997. This is the first report on the effects of short-term recombinant human leptin administration on reproductive function and bone turnover in women with hypothalamic amenorrhea. This work has implications for potential beneficial effects of leptin administration in AN patients.
42. Chan JL, Mantzoros CS. Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa. Lancet 2005; 366:74-85. A comprehensive review of leptin physiology, the pathophysiology of leptin deficiency in undernutrition, and the potential role of leptin administration in improving reproductive function and bone density in hypothalamic amenorrhea and AN.
43. Miller KK, Grieco KA, Mulder J, et al. Effects of risedronate on bone density in anorexia nervosa. J Clin Endocrinol Metab 2004; 89:3903-3906. This is the first paper to report pilot data on treatment effects of a bisphosphonate drug and substantial increases in spinal bone density in women with active AN.
44. Golden NH, Iglesias EA, Jacobson MS, et al. Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2005; 90:3179-3185. This study is the first randomized, double-blind, placebo-controlled trial of the effects of a bisphosphonate drug in adolescent girls with AN.